Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The p38 MAPK-CREB pathway is a critical signaling cascade involved in cellular responses to stress, inflammation, and differentiation. p38 MAPK activates CREB by phosphorylation, which regulates transcription of genes important for cell survival, differentiation, and proliferation. This pathway plays significant roles in various diseases, including cancer and neurodegenerative disorders. While it is not a single target molecule, modulating this pathway can be therapeutic for several conditions.
Inhibition of p38 MAPK to reduce inflammation or cancer progression. Activation of CREB to enhance cell survival or differentiation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on p38 MAPK-CREB signaling pathway (p38-CREB pathway).